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Abstract 
Arrhythmogenic cardiomyopathy (AC), also known as arrhythmogenic right ventricular 
cardiomyopathy (ARVC), is a disease characterized by fatty or fibro-fatty myocardial 
replacement, predominantly in the right ventricle and to a lower extent the left ventricle. It is 
recognized as a disease affecting the cardiac intercalated disc. Clinically, it is associated with 
ventricular arrhythmias, although atrial arrhythmias and atrial histopathological changes 
characteristic of AC have occasionally been reported. The full extent of atrial involvement in AC 
has not been investigated. Therefore, we aimed to apply histopathology, immunochemical 
detection, immunolocalization and transmission electron microscopy (TEM) techniques to 
characterize the distribution of desmosomal and gap junction proteins at the intercalated disc in 
the atria of boxers with AC. We hypothesized that histological changes consistent with AC and 
alterations to the intercalated disc proteins are present in the atria of boxer dogs with AC.  The 
hearts from 14 control and 13 boxers with confirmed AC were studied. Right and left atrial 
sections from 11 boxers were examined by immunofluorescence.  Samples from 10 boxers were 
used for Western blot analysis. The intercalated disc proteins investigated were connexin 43 
(Cx43), connexin 45, connexin 40, plakoglobin, plakophilin-2, desmoplakin, and cadherin.  
Transmission electron microscopy was performed on the right and left atrial sections of 2 boxers 
and 2 controls.  Western blot band relative density indicated a significant decrease of Cx43 in the 
right atrium of affected boxers compared to controls.  There was no difference between controls 
and boxers for the other proteins investigated.  Immunofluorescence analysis showed that the 
number of Cx43 signals and the signal intensity for plakoglobin was decreased in the left and 
right atrium of affected boxers.  Transmission electron microscopy suggested disruption of the 
intercalated disc in affected boxers. In conclusion, these results indicate the alteration of 
intercalated disc proteins in the atrial myocardium of boxers, showing atrial involvement in 
viii 
 
addition to the ventricles. These findings support the use of the broader term of AC rather than 
ARVC to describe this disease.  The decrease in the amount of Cx43 in conjunction with the 
histological changes could represent the substrate for the atrial arrhythmias associated with AC.  
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Chapter 1 
 Introduction 
Arrhythmogenic cardiomyopathy (AC) is a myocardial disease characterized by 
ventricular arrhythmias, syncopal episodes and sudden death in human patients (Corrado, Basso 
et al. 2000).  The disease was originally described as a developmental condition affecting the 
right ventricle, and was therefore termed arrhythmogenic right ventricular dysplasia (Marcus, 
Fontaine et al. 1982). However, as the understanding of the disease has changed, so has the name 
of the disease.  The use of the term arrhythmogenic right ventricular cardiomyopathy (ARVC) 
became more common when it was recognized as a progressive cardiomyopathy, characterized 
by fatty or fibro-fatty replacement of the right ventricular myocardium, suggestive of an injury 
and repair process (Basso, Thiene et al. 1996).  Most recently, it has been shown that although 
the disease affects primarily the right ventricle, there is significant involvement of the left 
ventricular myocardium (Norman, Simpson et al. 2005).  Currently, it is widely accepted that 
both ventricles can be affected by the disease, which has led to an expert consensus and the 
suggestion to change the nomenclature of the disease from arrhythmogenic right ventricular 
cardiomyopathy to the broader term of arrhythmogenic cardiomyopathy (Basso, Corrado et al. 
2009; Sen-Chowdhry, Morgan et al. 2010). The disease has also been recognized in dogs, with 
boxer dogs being more commonly affected (Basso, Fox et al. 2004). 
In humans, arrhythmogenic cardiomyopathy has been linked to mutations of genes 
coding for proteins of the desmosomes in the intercalated disc (Marcus, McKenna et al. 2010; 
Corrado, Basso et al. 2011).  The intercalated disc is responsible for cell adhesion between 
cardiomyocytes and is formed by three types of intercellular connections: desmosomes, adherens 
junctions and gap junctions.  The desmosomes and adherens junctions are responsible for the 
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mechanical coupling between cardiac myocytes; the gap junctions facilitate cell-to-cell 
propagation of the electrical impulse.  Mutations in the genes coding for plakoglobin (JUP), 
desmoplakin (DP), plakophilin-2 (PKP2), desmoglein-2 and desmocollin-2, all proteins of the 
desmosomes, have been linked to AC in humans (Rampazzo, Nava et al. 2002; Gerull, Heuser et 
al. 2004; Heuser, Plovie et al. 2006; Pilichou, Nava et al. 2006).  Immunofluorescence of 
ventricular tissue in humans and boxers with AC has shown a decrease in the signal of various 
desmosomal proteins at the level of the intercalated disc, which is more pronounced for 
plakoglobin (Oxford, Everitt et al. 2007; Asimaki, Tandri et al. 2009).  Moreover, transmission 
electron microscopy (TEM) has shown a decrease in the number of desmosomes in the right 
ventricle of both humans and boxers with AC (Basso, Czarnowska et al. 2006; Oxford, Danko et 
al. 2011).  In addition to the desmosomes, gap junctions are also affected by AC.  Decreased 
expression and altered localization of connexin 43 (Cx43), a protein of the gap junctions, has 
been identified via immunofluorescence of ventricular tissue in humans and boxers with AC 
(Kaplan, Gard et al. 2004; Oxford, Everitt et al. 2007).  Transmission electron microscopy of left 
and right ventricular samples of boxers with AC confirmed a decrease in the number of gap 
junctions at the level of the intercalated disc (Oxford, Danko et al. 2011).  Alterations of gap 
junctions have been linked to arrhythmogenesis and could contribute to the arrhythmias seen 
with AC (Severs, Bruce et al. 2008; Basso, Corrado et al. 2009) 
During evaluation of boxers presented to the cardiology services of Louisiana 
State and Cornell University, it was noticed that, in addition to the ventricular arrhythmias, some 
boxers with AC also have atrial arrhythmias.  Atrial arrhythmias and sinus node dysfunction 
have occasionally been reported in humans and boxers with AC (Harpster 1983; Nogami, Adachi 
et al. 1990; Takemura, Kono et al. 2008; Thomason, Kraus et al. 2008; Chu, Zado et al. 2010).  It 
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is possible that these atrial arrhythmias could be the cause of syncopal episodes in some boxers 
with AC.  Syncopal episodes as a result of bradyarrhythmias and sinus node dysfunction have 
been reported previously in boxers with ventricular tachycardia (Thomason, Kraus et al. 2008).  
Atrial histopathological changes consistent with AC have been reported before in both humans 
and boxer dogs (Nogami, Adachi et al. 1990; Basso, Fox et al. 2004).  However, careful 
evaluation of the atrial tissue in AC has not been performed.  Therefore, the degree to which AC 
can affect the atrial myocardium is unknown. 
We aimed to investigate if the atrial myocardium of boxers with AC is affected by the 
disease and whether alterations in the desmosomal and gap junction proteins at the level of the 
intercalated disc are present in the atrial tissue of boxers with AC.  We explored this question by 
using histopathology, immunochemical detection, immunolocalization, and TEM to characterize 
the distribution of desmosomal and gap junction proteins at the level of the intercalated disc in 
boxer dogs.  We hypothesized that histological changes consistent with AC and alterations of the 
proteins of the intercalated disc are present in the atria of boxer dogs with AC.  If present, these 
changes could be responsible for the atrial arrhythmias seen with AC. 
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Chapter 2 
 Literature Review 
Historical perspective on arrhythmogenic cardiomyopathy 
In people, arrhythmogenic cardiomyopathy is an inherited myocardial disease 
characterized by fatty or fibro-fatty replacement of the right ventricular myocardium and is 
associated with ventricular arrhythmias and sudden death (McKenna, Thiene et al. 1994; 
Richardson, McKenna et al. 1996; Fontaine, Fontaliran et al. 1998).  Early pathological changes 
may be limited to an area demarcated by the free wall of the right ventricular inflow tract, 
outflow tract and apex, known as the “triangle of dysplasia” (Marcus, Fontaine et al. 1982; 
Marcus, McKenna et al. 2010).  Progression of the disease leads to broader right ventricular 
involvement and in many cases, left ventricular involvement as well (Corrado, Basso et al. 
1997).  In 1982, Marcus et al. reported 24 cases of right ventricular dysplasia with  fatty 
replacement of the right ventricle (Marcus, Fontaine et al. 1982).  At the time, the disease was 
believed to be a developmental disorder, hence its designation as ventricular dysplasia (Basso, 
Thiene et al. 1996; Azaouagh, Churzidse et al. 2011).  Thiene et al. described the autosomal 
pattern of inheritance of AC in a group of people from Veneto, a northeast region of Italy, in 
1988 (Thiene, Nava et al. 1988).  These affected individuals suffered from a right ventricular 
cardiomyopathy with ventricular arrhythmias leading to palpitations or syncopal episodes.  
However, in many of these individuals, sudden death was the first sign of disease. Human 
disease prevalence varies based on geographical location but it has been estimated to range from 
1:1000 to 1:5000 individuals (Basso, Corrado et al. 2009; Marcus, McKenna et al. 2010).    
In veterinary medicine, AC is mainly thought of as a canine disease, although the first 
veterinary report of AC was made in a group of cats in 2000 (Fox, Maron et al. 2000).  However 
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before this report, a primary myocardial disease, characterized by ventricular arrhythmias, 
syncope episodes and sudden death had long been described in boxer dogs and termed “boxer 
cardiomyopathy” (Harpster 1983; Harpster 1991).  Pedigree analysis of boxers affected by 
ventricular arrhythmias has shown that these ventricular arrhythmias are inherited as an 
autosomal dominant trait in certain boxers (Meurs, Spier et al. 1999).  It is likely that these early 
reports of “boxer cardiomyopathy” and inherited ventricular arrhythmias corresponded to a 
manifestation of AC.  In 2004, Basso et al. first suggested that “boxer cardiomyopathy” may be a 
possible animal model of AC (Basso, Fox et al. 2004).  They described the spontaneously 
occurring inherited “boxer cardiomyopathy” as being characterized by fibro-fatty infiltration of 
the right ventricular myocardium, and to a lesser extent the left ventricular and atrial 
myocardium.  Clinically, the disease was characterized by ventricular tachycardia, right 
ventricular enlargement, syncope and sudden death, resembling the manifestation of AC in 
humans.  AC has also been documented, although less frequently, in other breeds including 
English bulldogs (Santilli, Bontempi et al. 2009; Santilli, Bontempi et al. 2011). 
Clinical perspective on arrhythmogenic cardiomyopathy  
The clinical presentation of AC is similar in both humans and animals.  There are three 
stages to the disease that are usually observed in succession as AC worsens:  1) Initially, the 
patient is asymptomatic and ventricular arrhythmias are an incidental finding during physical 
examination for an unrelated condition.  2) The patient presents for signs associated with 
ventricular arrhythmias, including syncope, episodic weakness or palpitations (in humans).  3) 
The patient presents with signs of congestive heart failure secondary to systolic dysfunction and 
frequently a history of weakness or syncope related to the arrhythmias (Harpster 1983; Harpster 
1991; Meurs 2004; Marcus, McKenna et al. 2010).  However, as previously mentioned, in some 
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cases sudden death is the first and only sign of the disease.  In this disease, arrhythmias seem to 
be triggered by strenuous activity (Azaouagh, Churzidse et al. 2011). Therefore, people 
diagnosed with AC are encouraged not to participate in sports. 
The most common physical examination finding reported, in both boxers and humans, is 
the detection of an arrhythmia; this can be either single premature beats or paroxysms of 
tachycardia. On occasion, the arrhythmia is permanent when atrial fibrillation is present.  
Another physical examination abnormality common with AC is the presence of a systolic 
murmur on auscultation. Apical systolic murmurs result from mitral or tricuspid insufficiency 
from the annular dilation that accompanies cardiomegaly. Less frequently, a cardiac gallop is 
detected (Harpster 1983; Harpster 1991; Meurs 2004).  Left basilar systolic murmurs may be 
noted in some boxers, but these should not be linked to AC as they are usually physiologic or 
secondary to subaortic stenosis (Meurs 2004; Hariau and Carpenter 2010).   
Electrocardiography (ECG) plays an integral part in the clinical diagnosis of AC.  The 
most common electrocardiographic change noted is ventricular ectopy, in the form of ventricular 
premature complexes (singles, couplets, triplets or bigeminy) or ventricular tachycardia.  The 
ventricular ectopic beats tend to arise from the right ventricular myocardium, and are classically 
described as having a left bundle branch block pattern morphology with a predominantly positive 
deflection of the QRS complex in leads II, III and aVF (Kraus, Moïse et al. 2002; Basso, Fox et 
al. 2004; Meurs 2004; Cox, van der Smagt et al. 2009).  If severe, the ventricular tachycardia can 
lead to syncopal episodes and potentially sudden death.  The presence of conduction 
abnormalities manifested as abnormal late potentials measured by signal averaged 
electrocardiography has also been associated with AC in both humans and boxers (Spier and 
Meurs 2004; Marcus, McKenna et al. 2010).  Humans with AC can also have prolonged P-wave 
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duration and abnormalities in P-wave morphology, suggesting that the conduction abnormalities 
are not limited to the ventricles and that the atria may also be affected (Platonov, Christensen et 
al. 2011).  In both humans and boxers with AC, atrial arrhythmias such as supraventricular 
tachycardia and atrial fibrillation have been reported to occur occasionally; atrioventricular block 
and sinus node dysfunction have been observed infrequently (Harpster 1983; Nogami, Adachi et 
al. 1990; Harpster 1991; Baumwart, Meurs et al. 2005; Takemura, Kono et al. 2008; Thomason, 
Kraus et al. 2008; Chu, Zado et al. 2010).  If severe enough, these atrial arrhythmias could also 
lead to syncope or contribute to the progression to heart failure in human and veterinary patients 
afflicted with AC.  Because arrhythmias can occur intermittently, AC should not be ruled out if 
they are absent on a screening electrocardiogram.  The frequency of the ventricular beats can 
have as much as an 80% day to day variation with AC (Spier and Meurs 2004).  To increase the 
possibility of identifying these arrhythmias, 24-hour Holter monitoring is recommended if there 
is evidence of arrhythmia on auscultation or a history of clinical signs such as syncope (Meurs 
2004). On occasion, it may be necessary to perform additional Holter recordings or use an event 
monitor to increase the likelihood of arrhythmia detection (Meurs and Spier 2009).  In humans, 
the presence of  >500 ventricular beats in 24 hours is considered in the criteria for the diagnosis 
of AC (Corrado, Basso et al. 2011).  In boxers the presence of >100 ventricular beats in 24 hours 
is suggestive of AC, especially if these ectopic beats are present in the form of couplets, triplets, 
bigeminy or ventricular tachycardia (Meurs and Spier 2009; Stern, Meurs et al. 2010).  A Holter 
monitoring screening scheme has been suggested by Meurs et al., based on the number of 
ventricular premature complexes (VPCs) per 24 hours of 600 asymptomatic boxer dogs. It 
separates the affected animals into 5 groups:  1) 0-50 VPCs; within normal limits 2)  51-100 
VPCs; indeterminate 3) 100-300 VPCs; suspicious 4) 100-300 VPCs with increased complexity 
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(couplets, triplets or ventricular tachycardia) or 300-1000 VPCs; likely affected 5) Greater than 
1000 VPCs; affected, consider treatment (Meurs and Spier 2009).  This classification should not 
be used alone but instead combined with all the other diagnostic findings before making 
recommendations. It should be noted that neither the number of VPCs nor the complexity of the 
arrhythmias can be used as a sole factor to predict the risk of an animal to become symptomatic 
for the disease (Meurs and Spier 2009).  
Echocardiographic findings of AC can be highly variable.  Although AC is a primary 
myocardial disease, structural changes may only be present on histopathology and not be evident 
on echocardiography (Meurs 2004).  The expected findings on echocardiography vary depending 
on the stage of disease progression.  The majority of asymptomatic boxers, as well as most dogs 
suffering from syncopal episodes, have normal echocardiograms, but signs of depressed 
ventricular function and chamber dilation are reported on occasion. Atrial enlargement also 
develops as a result of ventricular dysfunction, and is more pronounced in dogs with congestive 
heart failure.  Although the complex shape and mechanical properties of the right ventricle 
prevents accurate and systematic evaluation via echocardiography (Baumwart, Meurs et al. 
2009), careful examination of the right side of the heart of affected dogs may reveal localized 
right ventricular dilation and dysfunction (Santilli, Bontempi et al. 2011).  Increases in right 
ventricular inflow and right ventricular outflow tract dimensions are typically noted during 
echocardiography in humans with AC, with approximately 62% of the patients having abnormal 
right ventricular function (Yoerger, Marcus et al. 2005).  Right ventricular outflow tract dilation 
in combination with regional right ventricular akinesia, dyskinesia, or aneurysm are part of the 
echocardiographic diagnosis criteria of AC in humans (Marcus, McKenna et al. 2010). 
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Decreased right ventricular ejection fraction has been shown in AC boxers when 
measured via ECG- gated magnetic resonance imaging (Baumwart, Meurs et al. 2009).  
Ultimately, disease progression may lead to biventricular failure, making it difficult to 
distinguish AC from idiopathic dilated cardiomyopathy (Corrado, Basso et al. 1997; Corrado, 
Basso et al. 2000; Baumwart, Meurs et al. 2005; Marcus, McKenna et al. 2010).  
Because of the difficulty in diagnosing AC, as well as its multiple possible 
manifestations, a list of diagnostic criteria was created for AC in humans in 1994.  The “Task 
Force Criteria” combine data collected from multiple diagnostic tools, including ECG, 
echocardiography, genetic testing, and histopathology to establish a clinical diagnosis of AC 
(McKenna, Thiene et al. 1994; Corrado, Basso et al. 2011).  The findings from these tests are 
divided into a set of major and minor criteria for the diagnosis of AC (Table 1.1).  A positive 
diagnosis of AC based on the list of “Task Force Criteria” necessitates the presence of two major 
criteria, one major plus two minor criteria or four minor criteria (McKenna, Thiene et al. 1994).   
The criteria were recently updated to incorporate recent advances, thereby increasing 
their diagnostic potential while maintaining their specificity for the disease (Marcus, McKenna et 
al. 2010).  The modified list gives more emphasis to the family history of the patient. Indeed, a 
family history of confirmed disease increases the likelihood of disease in an individual from 
1:1000-1:5000 to 1:2 (Marcus, McKenna et al. 2010).  Because the “Task Force Criteria” were 
designed for the diagnosis of AC in humans, there are a number of factors that cannot be easily 
applied to boxers with AC.  However, others are shared between humans and boxers, which 
makes these guidelines useful for the diagnosis of AC in boxers.  
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Table 1.1. Original Task Force Criteria 
 
Major 
 
Minor 
 
Global or regional dysfunction and structural alteration 
 Severe dilation and reduction of RV ejection 
fraction with no (or only mild) LV impairment 
 Localized RV aneurysms (akinetic or dyskinetic 
areas with diastolic bulging) 
 Severe segmental dilation of the RV 
 Mild global RV dilation and/or ejection fraction 
reduction with normal LV 
 Mild segmental dilation of the RV 
 Regional RV hypokinesia 
Tissue characterization of wall 
 Fibrofatty replacement of myocardium on 
endomyocardial biopsy 
 
Repolarization abnormalities 
  Inverted T waves in right precordial leads (V2 and 
V3) (people age > 12 years, in the absence of right 
bundle-branch block) 
Depolarization/conduction abnormalities 
 Epsilon Waves or localized prolongation (>110 
ms) of the QRS complex in right precordial leads 
(V1 to V3) 
 Late potentials (signal averaged ECG) 
Arrhythmias 
  Left bundle-branch block-type ventricular 
tachycardia (sustained and nonsustained) (ECG, 
Holter, exercise) 
 Frequent ventricular extrasystoles (>1000 per 24 
hours) (Holter) 
Family history 
 Familial disease confirmed at necropsy or surgery  Family history of premature sudden death (<35 
years of age) due to suspected AC 
 Familial history (clinical diagnosis based on 
present criteria) 
 
11 
 
Criteria of particular interest for the diagnosis of AC in boxers include the presence of 
sustained or nonsustained ventricular tachycardia with left bundle branch block morphology, the 
number of ventricular beats in a 24-hour period, the presence of a family history of the disease, 
the finding of regional structural or functional changes via imaging (echocardiography, MRI), 
and histopathology showing fatty or fibro-fatty replacement of the ventricular myocardium.  
Among all the different factors evaluated by the group forming the task force, histopathological 
evaluation of the myocardium remained the gold standard for a definitive diagnosis of AC 
(McKenna, Thiene et al. 1994; Marcus, McKenna et al. 2010).  
Treatment of AC aims at alleviating the clinical signs, as there is no specific treatment for 
the disease. In the absence of clinical signs and if the arrhythmia burden is mild, no treatment 
may be necessary.  However, if the arrhythmia is of clinical concern or if there are collapsing 
episodes, antiarrhythmic therapy is implemented. In dogs, common protocols for the treatment of 
ventricular arrhythmias include the use of sotalol monotherapy or a combination of mexiletine 
and a -blocker (Meurs and Spier 2009).  The response to antiarrhythmic therapy should be 
assessed via 24-hour Holter monitoring, keeping in mind that there could be as much as an 80% 
daily variation in the number of ventricular ectopies in dogs with AC (Spier and Meurs 2004).  In 
cases where congestive heart failure is present, standard heart failure therapy is initiated with the 
need for addition of antiarrhythmic therapy determined by the patients underlying rhythm.  The 
administration of antiarrhythmic drugs can lead to a reduction in clinical signs and therefore 
improve quality of life but the risk for sudden death from AC is not decreased by these 
medications.  In boxers, the use of antiarrhythmic medications as the sole therapy for controlling 
these malignant arrhythmias is the current standard of care.  However, in humans the use of 
implantable cardioverter defibrillators (ICDs) in combination with antiarrhythmic medications is 
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recommended in individuals with syncope or hemodynamically unstable ventricular tachycardia 
to reduce the clinical signs and the risk of sudden death associated with AC (Azaouagh, 
Churzidse et al. 2011; Corrado, Basso et al. 2011).  Implantable cardioverter defibrillator (ICD) 
therapy is not widely available in dogs and its clinical use is limited to a few case reports 
(Nelson, Lahmers et al. 2006; Pariaut, Saelinger et al. 2011). A recent study, evaluating the use 
of ICDs in 9 healthy dogs showed that ICDs can be safely implanted in dogs with adequate 
safety margins allowing successful defibrillation therapy (Pariaut, Saelinger et al. 2012). 
However, additional research is needed to improve ICD therapy in dogs. With continued 
research, ICD therapy may become more available in veterinary medicine, and it may become an 
important tool in the treatment of AC. 
Histopathological perspective on arrhythmogenic cardiomyopathy 
The typical histopathological changes associated with AC are fatty or fibro-fatty 
replacement of the right ventricular myocardium, which exhibits features of myocyte 
degeneration and death suggesting an injury and repair process (Basso, Thiene et al. 1996; Basso 
and Thiene 2005). The fatty or fibro-fatty replacement of the myocardium tends to start in the 
subepicardium, extending to the midmyocardium and eventually becoming transmural as the 
disease progresses (Basso, Corrado et al. 2009).  Fatty infiltration of the right ventricle alone 
should not be considered as a sole diagnostic factor of AC as some intramyocardial fat can be a 
normal finding in the right ventricle (Azaouagh, Churzidse et al. 2011).  Also, in both the fatty 
and fibro-fatty form of AC, there will be some degree of degenerative changes of the myocytes 
as well as interstitial fibrosis histologically (Basso and Thiene 2005).  What has been viewed as 
“the classic” form of AC, is a disease process that would affect primarily the right ventricle.  
However, involvement of the left ventricular myocardium has been well documented in both 76 
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% of humans and 48 % of boxers with AC (Corrado, Basso et al. 1997; Basso, Fox et al. 2004).  
Fatty or fibro-fatty changes in the left and right atrial tissue have also been reported in AC with 8 
out of 23 boxers (35%) having atrial changes in the first report of AC in this breed (Basso, Fox et 
al. 2004). Atrial changes have been documented in humans case reports; however, research 
studies of atrial tissues are not available probably due to inadequate examination of atrial tissues 
(Nogami, Adachi et al. 1990; Corrado, Basso et al. 1997).  In addition to the typical fatty or 
fibro-fatty replacement, myocarditis associated with apoptosis has been commonly documented 
in humans and boxers with AC, with the fibro-fatty form of the disease showing a higher 
occurrence of myocarditis (Basso, Thiene et al. 1996; Basso, Fox et al. 2004).  In the first report 
of AC in boxers, focal or multifocal lymphocytic infiltrates characteristic of myocarditis were 
reported in the right ventricle (61%), left ventricle (70%), and atria (17%) of AC boxers (Basso, 
Fox et al. 2004). At this time, it has not been determined whether myocarditis is a reaction to cell 
death or contributes to it (Basso, Thiene et al. 1996; Corrado, Basso et al. 2011).  However, it is 
believed that myocarditis in AC patients could be a factor in the development of life-threatening 
arrhythmias (Basso, Fox et al. 2004; Corrado, Basso et al. 2011).  Despite the importance of 
histopathology for a final diagnosis of AC, the clinical diagnosis of AC should be based on the 
combination of the clinical criteria described by the “Task force”.  Histopathological evaluation 
requires an invasive procedure, such as endomyocardial biopsy, that may not be feasible in all 
patients, especially in veterinary medicine.  In addition, although diagnosis is definitive when 
fatty or fibro-fatty myocardial replacement is present, segmental involvement of the myocardium 
could lead to false negative diagnosis considering the small size of the biopsy samples (Marcus, 
McKenna et al. 2010; Azaouagh, Churzidse et al. 2011). 
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Molecular perspective on arrhythmogenic cardiomyopathy 
In humans, AC is usually found to be an autosomal dominant inherited disease with 
incomplete penetrance. In addition, there are some recessive forms, Naxos disease and Carvajal 
syndrome, that are associated with skin lesions (Kaplan, Gard et al. 2004; Marcus, McKenna et 
al. 2010).  In 1998, Naxos disease was mapped to chromosome 17 (Coonar, Protonotarios et al. 
1998).  The external phenotype of the disease made it ideal for the study of AC as cardiac 
disease could be assertively assigned by the presence of the skin and hair changes (McKoy, 
Protonotarios et al. 2000).  As a matter of fact, it was the study of this disease that introduced the 
idea that AC could be a cell junction disease.  In 2000, the first AC gene mutation was identified, 
when McKoy et al. discovered that a mutation in the Plakoglobin gene, affecting the C-terminal 
of the protein, was responsible for Naxos disease (McKoy, Protonotarios et al. 2000).  
Plakoglobin is an important protein for the formation of cell-to-cell connections in many tissues.  
The fact that the skin and the heart share similar cell-to-cell connections explains how a mutation 
in a single gene, corresponding to a protein of the desmosome and adherens junctions, can cause 
clinical signs associated with both organs.  Currently, it is widely accepted that AC is a disease 
of the intercalated disc and more specifically of the desmosomes that compose it.  The 
intercalated discs are the end-to-end connection of cardiomyocytes and are formed by three types 
of intercellular junctions: desmosomes, adherens junctions and gap junctions.  The desmosomes 
and adherens junctions are primarily responsible for the mechanical coupling between 
cardiomyocytes, whereas the gap junctions facilitate cell-to-cell electrical impulse propagation.  
In recent years, mutations in many more genes that code for proteins of the desmosomes and 
adherens junctions have been shown to be the cause of AC.  For example, a mutation in 
desmoplakin (a desmosomal protein) has been identified as the cause for Carvajal syndrome 
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(Norgett, Hatsell et al. 2000).  Autosomal dominant mutations in plakoglobin (JUP), 
desmoplakin (DP), plakophilin-2 (PKP2), desmoglein-2 and desmocollin-2, all proteins of the 
desmosome, have subsequently been linked to AC in humans (Rampazzo, Nava et al. 2002; 
Gerull, Heuser et al. 2004; Heuser, Plovie et al. 2006; Pilichou, Nava et al. 2006).  In 2005, 
Norman et al. described a dominant mutation in desmoplakin that produces a primarily left-sided 
form of AC (Norman, Simpson et al. 2005).  In addition to the mutations of desmosomal 
proteins, mutations in the genes coding for the ryanodine receptor (RYR2) and transforming 
growth factor beta-3 have also been reported to be associated with AC (Tiso, Stephan et al. 2001; 
Beffagna, Occhi et al. 2005).  The latest gene to be identified as a cause of AC was the 
transmembrane protein 43 (TMEM43) gene; little is known about this gene at this time but it is 
suspected to play a role in an adipogenic pathway (Merner, Hodgkinson et al. 2008; Corrado, 
Basso et al. 2011).  Despite the discovery of many of the genes that can lead to AC, currently 
over 50% of patients with AC still do not have an identifiable genetic mutation (Saffitz 2009).  In 
boxers with AC, a reduction in the right and left ventricular expression of the ryanodine receptor 
and the left ventricular levels of calstabin-2, a protein that modulates the RYR2 receptor 
function, have been demonstrated (Meurs, Lacombe et al. 2006; Oyama, Reiken et al. 2008). 
However, only one genetic mutation has been associated with AC to date, the striatin gene that 
codes for a protein that colocalizes with JUP, PKP2, and DP in the intercalated disc (Meurs, 
Mauceli et al. 2010).  In this study, boxers positive for the striatin mutation had a higher number 
of VPCs on 24 hour Holters, with homozygous dogs being more affected than dogs that are 
heterozygous for the mutation.  Immunofluorescence of ventricular tissue in AC boxers has 
shown decreased signal for PKP2, DP, and a complete lack of JUP in the intercalated disc 
(Oxford, Everitt et al. 2007).  Immunofluorescence has gained interest as a reliable way to show 
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the altered desmosomal proteins, helping in the diagnosis of AC.  In fact, in humans, 
immunofluorescence for JUP has been shown to have 91% sensitivity and 82% specificity as a 
diagnostic test for AC (Asimaki, Tandri et al. 2009). It has been suggested that 
immunofluorescence for desmosomal proteins, like JUP, could be incorporated into the 
diagnostic criteria in the future.  Transmission electron microscopy has also been used to 
evaluate the intercalated disc area in both boxers and humans, showing a significantly lower 
number of desmosomes the right ventricle of AC affected individuals compared to controls 
(Basso, Czarnowska et al. 2006; Oxford, Danko et al. 2011).  The fact that over 50% of humans 
do not have an identifiable genetic mutation and that boxers have decreased immunofluorescence 
signal for some desmosomal proteins, similar to human AC patients with confirmed genetic 
mutations, suggests that the desmosomal proteins in boxers with AC are also defective, even if a 
specific genetic mutation in these proteins has not been discovered at this time.  
In humans, not all individuals in which a genetic mutation linked to AC is present will 
develop the phenotypical changes associated with the disease given the incomplete penetrance 
and variable expression of these genes (Corrado, Basso et al. 2011).  Despite the recognition of 
AC as a disease of the cardiac desmosomes, the specific mechanism of how disruption of these 
desmosomal proteins leads to AC is still unknown.  The most accepted hypothesis is that the 
integration of defective desmosomal proteins into the intercalated disc facilitates the detachment 
of myocytes at this location, especially during periods of mechanical stress, leading to the 
degeneration and apoptosis of cardiomyocytes with development of fibro-fatty replacement as a 
result of the repair process (Corrado, Basso et al. 2011).  Because the desmosomes and adherens 
junctions provide the mechanical connection between myocytes, it seems logical that disruption 
to their integrity would lead to myocyte detachment and damage.  However, to view this as a 
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simple mechanical cause and effect scenario could be oversimplifying what actually occurs, as it 
has also been shown that intercalated disc proteins have a complex interaction with each other 
and can also play a part in signaling pathways.  Desmosomes have been proposed to regulate 
transcription genes involved in adipogenesis and apoptosis.  For example, it has been suggested 
that nuclear translocation of plakoglobin, in desmoplakin deficient mice, mediates changes in the 
Wnt pathway causing the differentiation of cardiomyocytes into the adipocyte lineage (Garcia-
Gras, Lombardi et al. 2006; Delmar and McKenna 2010).  Decreases in Ankaryn-G, a 
cytoskeletal adaptor protein that is associated with the voltage-gated sodium channels at the 
intercalated disc, in cultured myocytes has been shown to lead to decreased PKP-2 expression 
and decreased intercellular adhesion strength (Sato, Coombs et al. 2011).  Interestingly, a 
reciprocal relationship was also noted with a decrease in PKP-2 leading to a decrease in 
Ankaryn-G expression and decreased intercellular adhesion strength (Sato, Coombs et al. 2011).  
This serves to illustrate the complex and yet incompletely understood interaction between 
intercalated disc proteins that were previously viewed as independent complexes located within 
the same general area (Delmar 2012).  Therefore, it is likely that the combination of the 
mechanical forces, the interaction of the mutated desmosomal proteins with other intercalated 
disc components and signaling pathways lead to the altered intercalated disc integrity rather than 
any one mechanism on its own.  
Because of the previously discussed interaction between the intercalated disc 
components, genetic mutations affecting the desmosomal proteins do not only alter the integrity 
of the desmosomes and adherens junctions but also lead to altered gap junctions as these 
connections are usually found adjacent to the desmosomes in the intercalated disc. Gap junctions 
are composed of a collection of intercellular channels.  Each intercellular channel is composed of 
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a pair of connexons on each side of the plasma membrane.  Each connexon is composed of six 
connexin molecules.  There are 3 main connexin proteins expressed in cardiac tissue: connexin 
40 (Cx40), connexin 43 (Cx43) and connexin 45 (Cx45) (Severs, Bruce et al. 2008).  Connexin 
43 is the main connexin found in the gap junctions of ventricular tissue (Davis, Kanter et al. 
1994).  Immunofluorescence analysis of ventricular tissue in both affected humans and boxers 
has shown decreased Cx43 expression and altered localization, to the lateral aspect of the 
myocytes instead of forming part of the end to end connections (Kaplan, Gard et al. 2004; 
Oxford, Everitt et al. 2007).  These findings have also been confirmed via transmission electron 
microscopy with AC affected boxers having a decrease in the number of gap junctions at the 
level of the intercalated disc in both the right and left ventricle (Oxford, Danko et al. 2011).  Gap 
junctions only provide the electrical connection between cells and have been described as being 
particularly susceptible to shear stress (Saffitz, Hames et al. 2007).  Therefore, once the 
mechanical connection provided by desmosomes and adherens junctions has been disrupted, the 
gap junctions are not able to sustain the remaining forces.  Another theory on how damage to the 
desmosome affects the gap junction integrity is that the gap junction and desmosome are not two 
independent components of the intercalated disc but that on the other hand they are 
interconnected with molecular changes to one affecting the other.  An example of this can be 
seen by the fact that decreased expression of PKP-2 in cultured myocytes leads to decreased  
Cx43 expression, suggesting that increased shear stress is not the only factor altering gap 
junction expression in AC (Oxford, Musa et al. 2007).  Gap junction remodeling is not limited to 
the disease process in AC, but can occur as a consequence of disruption to the intercalated disc 
or cardiomyocyte integrity, as decreases and lateralization of gap junctions have also been shown 
to occur secondary to CHF in other cardiovascular diseases (Severs, Bruce et al. 2008).  
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Therefore, the alterations in gap junctions could be directly related to the pathogenesis of AC or 
a result of end stage disease leading to a “final common pathway” of disease regardless of the 
cause of cardiomyopathy (Vatta, Marcus et al. 2007).  However, alterations to the gap junctions 
have been shown to occur in AC before the presence of cardiac pathology (Kaplan, Gard et al. 
2004), suggesting that they are part of the initial pathological process in AC even if they also 
occur in the end stages of other cardiac diseases. Irrespective of the reason for gap junction 
alteration, it has been shown that alterations in their function and location can lead to 
arrhythmogenesis (Severs, Bruce et al. 2008).  For example, in a chimeric mouse model, 
heterogeneous Cx43 expression in the myocardium was linked to conduction abnormalities, 
contractile dysfunction, and occasional ventricular tachycardia (Gutstein, Morley et al. 2001).  
Therefore, it is likely that altered gap junction expression and localization contribute to the 
arrhythmogenic substrate created by the fatty or fibro-fatty infiltration of the myocardium in AC.    
In conclusion, AC is a disease dominated by ventricular arrhythmias. The substrate for 
these arrhythmias is likely a combination of the diffuse fatty or fibro-fatty myocardial 
replacement and an alteration in gap junction number and location at the molecular level.  While 
most of the attention has been directed to the life-threatening ventricular arrhythmias, one cannot 
ignore the occurrence of atrial arrhythmias with AC.  Therefore, we aim to investigate if the 
atrial myocardium of AC boxers is affected by the disease and whether alterations in 
desmosomal proteins and gap junctions can be detected in this tissue, potentially representing the 
anatomic substrate for the atrial arrhythmias. 
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Chapter 3   
Materials and Methods 
Samples 
Tissues were collected from 13 boxer dogs with a clinical diagnosis of AC at 3 
institutions, Louisiana State University, Cornell University and the University of Pennsylvania. 
Sample collection took place less than one hour after sudden death or euthanasia at the owner’s 
request because of concurrent disease or heart disease for which the prognosis was poor. Control 
samples from 14 mongrel dogs without cardiac disease, based on physical examination, heart 
weight to body weight ratio and gross examination of the hearts were obtained after euthanasia 
for a separate study.  Ten boxers had echocardiograms and 10 boxers had 24-Holter recordings 
available for a detailed analysis and quantification of arrhythmias. Genetic testing was performed 
as part of the clinical evaluation in 5 boxers. Full thickness right ventricular, left and right atrial 
samples were obtained. The samples were flash-frozen and saved at -80 ºC for western blot; 
fixed in 10% phosphate-buffered formalin and embedded in paraffin for histopathology and 
immunofluorescence; fixed in 1.25% gluteraldehyde and 2% formaldehyde in Cacodylate buffer 
(CAC) for transmission electron microscopy. 
Pathology 
Sections were cut in 5-µm thick slices. The left and right atria from all dogs were stained 
with hematoxylin and eosin for routine histopathologic evaluation and Masson trichrome to 
better characterize fibro-fatty infiltrates. The right ventricle of boxer dogs was also stained in a 
similar fashion to corroborate the diagnosis of AC. All the samples were classified as normal or 
as having fibro or fibro-fatty replacement by a blinded single investigator with expertise in 
cardiac pathology who was not aware of the group status. 
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Localization of intercalated disc proteins by immunofluorescence 
Immunofluorescence was performed on full thickness left and right atrial samples of 14 
control and 11 boxer dogs.  The samples were fixed in 10% buffered formalin, embedded in 
paraffin and sectioned into 5-µm thick slices. Sections were deparaffinized and antigen retrieval 
performed with citrate buffer. Sections were blocked in 10% normal goat serum (Invitrogen, 
Carlsbad, CA) or 5% bovine serum albumin, 0.1% triton buffer for 90 minutes, and then 
incubated overnight at 4°C with the appropriate primary antibodies. After incubation, the 
samples were washed in phosphate-buffered saline (PBS) and incubated with the appropriate 
secondary antibodies for 1 hour at room temperature. The samples were mounted with 
VECTASHIELD Mounting Medium with DAPI (Vector Laboratories, Inc., Burlingame, CA) 
and examined with an Olympus IX71 inverted microscope. The secondary antibodies used were 
Alexafluor 484 goat anti-rabbit and Alexafluor 598 goat anti-mouse (Molecular Probes, Division 
of Invitrogen, Carlsbad, CA). During immunofluorescence analysis, both the distribution and the 
intensity of the immunoreactive signal were evaluated.  Five 20X fields from each sample were 
evaluated and selected for analysis. A total of 10 intercalated discs were selected and the 
immunoreactive signal intensity of the protein tested was assessed with the software ImageJ 
(National Institutes of Health, Bethesda, MD), as previously described (Gavet and Pines 2010).  
The intensity per pixel of each intercalated disc was measured and the intensity per pixel of an 
equally sized area of background adjacent to the intercalated disc was subtracted.  
The following primary antibodies were tested: polyclonal rabbit anti-cadherin (Sigma 
Aldrich, St. Louis, MO), polyclonal rabbit anti-desmoplakin (Santa Cruz Biotechnology, Inc., 
Santa Cruz, CA), monoclonal mouse anti-plakoglobin (Sigma Aldrich, St. Louis, MO), 
polyclonal rabbit anti-connexin 43 (EMD Millipore, Billerica, MA), polyclonal rabbit anti-
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connexin 40 (Invitrogen, Carlsbad, CA), polyclonal rabbit anti-connexin 45 (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA) and monoclonal mouse anti-plakophilin 2a and 2b 
(Meridian Life Science, Inc., Memphis, TN).  
Immunochemical detection of intercalated disc proteins 
Western blot was performed on left and right atrial samples of 14 control and 10 boxer 
dogs. Frozen tissue samples were homogenized in Laemmli buffer and protein amount measured 
by RC DC protein assay (Bio-Rad Laboratories, Inc., Hercules, CA). Proteins were separated by 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using a 4% to 15% 
precast polyacrylamide gradient gel (Bio-Rad Laboratories, Inc., Hercules, CA), transferred onto 
nitrocellulose, blocked for 1 hour at room temperature with 5% non-fat milk in PBS-Tween 
(0.2%), and then incubated overnight at 4°C with the appropriate primary antibodies. To ensure 
equal loading, blots were stripped with Restore Western Blot Stripping Buffer (Thermo Fisher 
Scientific, Inc., Rockford, IL), blocked once more with 5% non-fat milk in PBS-Tween for 1 
hour at room temperature, and then incubated with anti-beta Actin antibody (Abcam, Cambridge, 
MA).  Western blot band relative density was calculated for all the protein tested using the 
software ImageJ (National Institutes of Health, Bethesda, MD), as outlined in the ImageJ 
documentation (Schneider, Rasband et al. 2012). Student’s t test was used to compare the left 
and right atrial western blot band relative density, of each protein tested, of control dogs to that 
of boxer dogs.  
The following primary antibodies were used: polyclonal rabbit anti-cadherin (Sigma 
Aldrich, St. Louis, MO), monoclonal mouse anti-desmoplakin (AbD Serotec, Kidlington, UK), 
monoclonal mouse anti-plakoglobin (Sigma Aldrich, St. Louis, MO ), polyclonal rabbit anti-
connexin 43 (EMD Millipore, Billerica, MA ), polyclonal rabbit anti-connexin 40 (Abcam, 
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Cambridge, MA), polyclonal rabbit anti-connexin 45 (Santa Cruz Biotechnology, Inc., Santa 
Cruz, CA ) and monoclonal mouse anti-plakophilin 2a and 2b (Meridian Life Science, Inc., 
Memphis, TN).  
Transmission electron microscopy  
 Transmission electron microscopy was performed on left and right atrial samples of 2 
control and 2 Boxer dogs. The samples were fixed for 1 hour with 1.25% glutaraldehyde and 2% 
formaldehyde in 0.1M sodium CAC buffer, pH 7.4.  After fixation, the samples were washed 
overnight in 0.1M CAC buffer (pH 7.4) with 5% sucrose.  They were then treated with osmium 
tetroxide, dehydrated, infiltrated using increasing concentrations of epoxy resin and embedded in 
epoxy resin. The tissue samples were sectioned to 75 nm thickness and stained with uranyl 
acetate followed by Reynold’s lead citrate and examined using a JEOL JEM-1011 transmission 
electron microscope equipped with AMT image capture engine.  For each section, 3-5 different 
fields were evaluated at 5,000X magnification.  The fields were selected based on the quality of 
the sectioning, lack of adipocyte infiltration (in AC dogs), and the amount of intercalated discs. 
Images were obtained at 15,000X magnification following the course of the intercalated discs.  
Statistical analysis  
 When indicated, results are expressed as mean ± SD or as median and range. D’Agostino 
and Pearson normality test was used to test for Gaussian distribution.  The western blot and 
immunofluorescence data was compared using the Student’s t test when the data was normally 
distributed data or the Mann-Whitney U test if the data was not normally distributed.  All 
calculations were performed using the statistical analysis software, GraphPad Prism version 5.0 
(GraphPad Software, San Diego CA). A value of P<0.05 was considered statistically significant. 
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Chapter 4 
Results  
Animals 
The demographic data of the control and AC boxers is summarized in table 4.1.  Hearts 
were obtained from 14 controls with a median age of 5 months (range 5-7 months), mean weight 
of 18.1 ± 2.7 kg, and 13 boxer dogs with a median age of 8 years (range 2-11 years), and a mean 
weight of 31.0 ± 3.6 kg.  The control 
dogs had a mean heart weight (g) to 
body weight (kg) ratio of 6.99 ± 
0.52.  For the AC boxers, this ratio 
could be calculated in 3 dogs; it was 
9 (dog #1), 8.37 (dog #5), and 9.21 
(dog #11).  Seven boxers had 
echocardiographic evidence of 
myocardial failure, with increased 
left ventricular end systolic diameter and decreased fractional shortening. Six boxers had atrial 
dilation determined by a left atrium to aortic root ratio of >1.8 (Table 4.2).  Nine boxers had 
supraventricular ectopy (SVE) noted via electrocardiography or 24-hour Holter recording at the 
time of the first evaluation before the administration of antiarrhythmic medication. The SVE 
were most commonly atrial premature complexes, couplets or triplets (6 boxers), followed by 
supraventricular tachycardia (2 boxers) and atrial fibrillation (1 boxer).  The number of 
supraventricular ectopic beats, in 24 hours, for the 6 boxers with atrial premature complexes are 
reported in table 4.2. Ventricular ectopy with a wide positive R wave in leads II, III and aVF was 
the predominant arrhythmia in all the boxers with the exception of two boxers who had primarily 
Table 4.1. Demographic Data of Controls and AC 
Boxers 
 Control AC Boxer 
Number of dogs 14 13 
Age  5 months  
(5-7 months) 
8 years 
(2-11 years) 
Body weight (kg) 18.1 ± 2.7 31.0 ± 3.6  
Sex  14 males 
0 females 
6 males 
7 females 
Intact 1/14 5/13 
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SVE (dog #3 with supraventricular tachycardia and dog #11 with atrial fibrillation). Six boxers 
had a history of syncopal episodes. The results of genetic testing for the striatin mutation were 
available in 5 boxers. Out of these 5 boxers, 2 were heterozygous (dog #6 and dog #13), 1 was 
homozygous (dog #4) and 2 were negative (dog # 8 and dog #12) for the striatin mutation.  
Table 4.2. Summary of Clinical Findings in 13 AC Boxers 
   Echocardiography 
 
Dog # Rhythm Clinical signs LVDD (cm) LVSD (cm) FS (%) LA/Ao 
 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
 
SVT/VPC 
VT 
SVT/VPC 
VT/APC (3) 
VT/APC (18) 
VT/APC (31) 
VT 
VT/APC (17) 
VT 
VT 
AF 
VPC/APC (1) 
VT/APC (60) 
 
 
S,PE 
L 
N 
S 
S,L 
S 
N 
N 
N 
N 
S 
N 
S 
 
 
6.2 
4.7 
5.1 
5.2 
5.1 
4.2 
- 
4.3 
4 
- 
5 
4 
- 
 
5.1 
4.3 
3.8 
4.2 
4.5 
3.1 
- 
3 
2.9 
- 
4.9 
2.2 
- 
 
 
18 
8.6 
25.5 
19 
12 
26 
- 
30 
27.5 
- 
2 
45 
- 
 
 
2.5 
2.3 
1.5 
1.8 
2.3 
1.8 
- 
2.1 
2 
- 
2.7 
1.5 
- 
   APC = atrial premature complexes; FS = percent fractional shortening; L = lethargy; LA/Ao = left 
atrial/aortic root ratio; LVDD = left ventricular diastolic diameter; LVDS = left ventricular systolic 
diameter; N = no clinical signs; PE = pulmonary edema; S = syncope; SVT = supraventricular tachycardia; 
VPC = ventricular premature complexes; VT = ventricular tachycardia. Number in parenthesis represents 
the number of supraventricular ectopic beats, in 24 hours. 
 
Pathological findings 
Upon histopathological evaluation, the tissues were classified as normal or as having 
fatty or fibro-fatty myocardial replacement by a single investigator who was not aware of the 
group status.  All 13 boxers showed the characteristic histopathological lesions of AC, with fatty 
(8/13) or fibro-fatty (5/13) replacement of the right ventricular myocardium.  Left atrial lesions 
were seen in 9 out of 12 boxers, with 8 classified as fatty and 1 classified as fibro-fatty 
myocardial replacement (Figure 4.1 A and B). The left atrium was not available for evaluation in 
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one boxer.  Right atrial lesions were identified in 12 out of 13 boxers, with 7 classified as fatty 
and 5 classified as fibro-fatty myocardial replacement (Figure 4.1 C-E). Two boxers had a 
normal left atrium and right atrial changes (dog #1 and dog #3) and 1 boxer (dog #10) had a 
normal left and right atrium. Inflammatory infiltrates suggestive of myocarditis were identified 
in the atria of 5 out of 13 AC boxers; infiltrates were seen in the right atrium alone in 4 boxers 
and in both the left and right atrium in 1 boxer. All the control dogs were classified as having 
normal atrial and right ventricular myocardium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Histopathology of the atrial myocardium from an AC boxer. (A) Left atrium 
(10X) showing relatively heterogeneous atrial myocardium. Box highlights section depicted 
in (B). (B) Higher magnification (30X) through the epicardium towards the mid mural 
region. Small, scattered clusters of adipocytes are present. There is some vertical tissue 
separation caused by processing artifact. (C) Right atrium showing generalized subepicardial 
replacement of myocytes with adipocytes, and focal regions of atrial tissue with generalized 
fatty infiltrate. Box contains the section highlighted to right. H&E, 10X. (D) Magnified 
section from (C) showing fatty replacement of myocytes. Occasional small, atrophic 
myocytes can be observed, surrounded by adipocytes. Mild interstitial fibrosis is present. 
H&E, 70X. (E) Same section as (D) stained with Masson trichrome stain to illustrate 
collagen (blue) located sub-epicardially and interstitially. 70X   
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Localization of intercalated disc proteins by immunofluorescence 
Immunofluorescence analysis was conducted on the left and right atrial sections for the 
following proteins: cadherin, PKP-2, DP, JUP (adherens junctions and desmosomes), Cx40, 
Cx43, and Cx45.   
Based on our samples we could not see a difference in the distribution of the 
immunoreactive signal for the adherens junctions and desmosomal proteins evaluated; nor was 
there a difference for the gap junction protein Cx40.  No immunoreactive signal for Cx45 was 
detected in the samples collected. A decrease in the number of Cx43 signals per 20X field was 
noted in the left and right atrium of AC boxers compared to the controls (Figure 4.2). However, 
the immunoreactive signal intensity for Cx43 was not different between the groups (Figure 4.2 
and 4.3).  Likewise, there was no difference in the immunoreactive signal for cadherin, Cx40, 
desmoplakin, and PKP-2 (Figure 4.3).  
 
 
Figure 4.2. Immunofluorescence of Connexin 43 showing decreased density of Cx43 in the 
AC boxers. The bright green fluorescence represents Cx43 and the blue fluorescence is DAPI 
staining the nucleus. (A) left atrium control dog, (B) left atrium AC boxer, (C) right atrium 
control dog, (D) right atrium boxer. Scale bars denote 50 μm. 
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The JUP immunoreactive signal intensity was significantly decreased in the right atrium 
of AC boxers when compared to the right atrium of the control dogs (optical density 6.19 ± 2.06 
versus 11.05 ± 5.31, P=0.009) (Figure 4.3 and 4.4). Similarly, the immunoreactive signal 
intensity for JUP was decreased in the left atrium of boxers when compared to the left atrium of 
the control dogs (optical density 7.53 ± 2.21 versus 10.15 ± 2.89, P=0.032) (Figure 4.3 and 4.4).  
Two boxers (dog #9 and #10) showed almost no detectable signal. Overall, the 
immunofluorescence results suggest the presence of altered desmosomal proteins and gap 
junction remodeling in the atrial myocardium of AC afflicted boxers.  
 
Figure 4.3. Optical density calculations of the immunoreactive signal from cadherin, 
Cx40, Cx43, DP, JUP, and PKP-2. The immunoreactive signal for JUP is decreased in the 
left and right atrium of the AC boxers. (*=P<0.05 and **=P<0.01) 
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Immunochemical detection of intercalated disc proteins 
 Western blot was performed from the left and right atrial tissue lysates for the same 
proteins evaluated via immunofluorescence.  There was no difference in the western blot band 
density for the desmosomal proteins:  JUP, PKP2, DP or Cadherin (Figure 4.5).   
 
 
 
Figure 4.4. Immunofluorescence for Plakoglobin showing decreased JUP immunoreactive 
signal in the AC boxers. The bright red fluorescence represents JUP and the blue 
fluorescence is DAPI staining the nucleus. (A) left atrium control dog, (B) left atrium AC 
boxer, (C) right atrium control dog, (D) right atrium boxer. Scale bars denote 50 μm. 
Figure 4.5. Representative western blots for Cadherin (Cad), Connexin 40 (Cx40), 
Connexin 45 (Cx45), Desmoplakin (DP), Plakoglobin (JUP), Plakophilin-2 (PKP2) and 
actin (loading control). (1) left atrium control, (2) left atrium AC boxer, (3) right atrium 
control, (4) right atrium boxer. 
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Similarly there was no difference in the band density for the gap junction proteins Cx40 
and Cx45 (Figure 4.5). However, the band density for connexin 43 was significantly decreased in 
the right atrium of AC boxers compared to the controls (band density Cx43/Actin 0.68 +/- 0.23 
versus 1.115 +/- 0.3, P=0.004) (Figure 4.6). Connexin 43 also appeared to be decreased in the 
left atrium; however this did not reach statistical significance, P=0.18. Overall, these results 
suggest a reduction in the total protein content of connexin 43 in the atria of AC afflicted boxers.   
 
 
Transmission electron microscopy 
 Transmission electron microscopy was performed in the left and right atrial samples of 2 
boxers and 2 controls. Adipocytes were identified in between the cardiomyocytes in the boxers 
but not in the controls (Figure 4.7). In the AC boxers, some areas of the intercalated disc 
appeared widened and altered in structure with the presence internalized gap junctions (Figure 
4.7), potentially indicating an increased remodeling of the intercalated disc of boxers with AC.  
The TEM results suggest that boxers afflicted with AC have disruption of the intercalated disc in 
the atrial myocardium. 
Figure 4.6.  Representative western blot for Cx43 and actin (loading control) showing 
decreased Cx43 in the right atrium of the AC boxers. The left atrium also appeared to have 
decreased Cx43 however this did not reach statistical significance. (*= P<0.05)   
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Figure 4.7. Electron micrograph of the intercalated disc (white arrows) showing the 
presence of adipocyte infiltration (black arrows) and disruption of the intercalated disc 
(black asterisk) in an AC boxers. Area inside the box shows the intercalated disc in a control 
dog. Scale bar denotes 500 nm 
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Chapter 5  
Discussion and Conclusion 
Arrhythmogenic cardiomyopathy is also known as arrhythmogenic right ventricular 
cardiomyopathy as it was previously described as a disease affecting solely the right ventricular 
myocardium; now it is widely accepted that the disease can also affect the left ventricular 
myocardium (Asimaki and Saffitz 2012).  However, it is unknown to what degree the atrial 
myocardium is affected by AC. The present study was designed to determine if the atrial 
myocardium of boxers with AC is also affected by the disease and whether alterations to the 
intercalated disc proteins are present in the atrial tissue of boxers with AC. The major findings 
were: 1) the presence of supraventricular arrhythmias in the AC boxers; 2) the atrial myocardium 
of the AC boxers has histopathological changes consistent with AC; 3) decreased JUP 
immunoreactive signal intensity without a change in the total western blot protein concentration; 
4) decreased number of Cx43 immunoreactive signals with a decreased in the western blot 
protein concentration.         
The Holter monitor data shows that even though AC is a disease dominated by 
ventricular arrhythmias, supraventricular ectopy was noted in 9 out of 13 boxers in the current 
study. In the majority of the boxers these arrhythmias were mild and of no clinical concern. 
However, in two boxers (dog # 3 and dog #11) supraventricular arrhythmia was the predominant 
rhythm.  While most of the attention has been directed to the life-threatening ventricular 
arrhythmias it is important that when present the atrial arrhythmias are not ignored. If severe 
enough, these arrhythmias could also lead to syncope or contribute to the progression to heart 
failure (Nogami, Adachi et al. 1990; Shinbane, Wood et al. 1997).  Atrial arrhythmias can be the 
result of atrial dilation and fibrosis secondary to heart failure (Burstein, Comtois et al. 2009). It is 
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possible that the arrhythmias seen in our study population were caused by atrial dilation and 
fibrosis secondary to heart failure, as the majority (60%) of the boxers had atrial dilation.  For 
example the boxer with atrial fibrillation (dog #11) had the largest left atrium to aortic root ratio 
in our study population.  Interestingly, the boxer with primarily SVT (dog #3) had no atrial 
dilation, suggesting that AC may contribute to the atrial arrhythmias independently of atrial 
dilation.  
Blinded histopathological assessment showed changes characteristic of AC in the atria of 
12 out of the 13 boxers and in none of the controls. The quality of the atrial sections for the 
boxer described to have no changes consistent with AC was poor, potentially contributing to an 
incorrect histopathological classification. The fatty or fibro-fatty myocardial replacement was 
present in the atria of boxer regardless of the presence of SVE.  Atrial histopathological changes 
characteristic of AC have been reported previously in 8 out of 23 boxers in the first report of AC 
in this breed (Basso, Fox et al. 2004). Inflammatory infiltrates suggestive of myocarditis were 
identified in the atria of 38% of the AC boxers in our study population. Inflammatory infiltrates 
characteristic of myocarditis have been reported in the right ventricle (61%), left ventricle (70%), 
and atria (17%) of AC boxers (Basso, Fox et al. 2004). These results indicate that even though 
AC has been reported to primarily affect the right and less frequently the left ventricular 
myocardium, the atrial myocardium is also affected by the disease. The fatty or fibro-fatty 
replacement of the atrial myocardium could represent the substrate for the atrial arrhythmias in 
AC boxers. However, the present study does not provide a direct link between the atrial 
arrhythmias and AC.     
  In order to further characterize the extent to which AC affects the atrial myocardium, we 
investigated whether alterations in the desmosomal proteins and gap junctions were present in 
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these boxers. Immunofluorescence analysis of the tissue showed that the cadherin 
immunoreactive signal intensity was similar to that of the controls, a finding that is consistent 
with other reports (Kaplan, Gard et al. 2004; Oxford, Everitt et al. 2007; Asimaki, Tandri et al. 
2009).  We failed to identify a difference in the immunoreactive signal intensity level for PKP2 
and DP.  In human AC, it has been shown that a decrease in the ventricular immunoreactive 
signal intensity for these proteins is variable and appears to be related to the type of genetic 
mutation (Asimaki, Tandri et al. 2009). A similar finding has been shown in boxers, with the 
ventricular immunoreactive signal intensity for PKP2 and DP having more variability in affected 
patients (Oxford, Everitt et al. 2007). On the other hand, a decrease in the ventricular 
immunoreactive signal intensity for JUP appears to be a more consistent finding in boxers, 
something that has also been shown in humans with AC regardless of the kind of genetic 
mutation (Oxford, Everitt et al. 2007; Asimaki, Tandri et al. 2009).  This decrease in ventricular 
immunoreactive signal intensity for JUP has been shown to be 91% sensitive and 82% specific 
for the diagnosis of AC in humans (Asimaki, Tandri et al. 2009).  In our population we found 
loss of the atrial immunoreactive signal intensity for JUP in the intercalated disc of AC boxers. 
Yet, western blot analysis demonstrated normal expression of JUP. Western blot  has previously 
failed to detect a difference in the expression of desmosomal proteins (JUP, PKP2, DP)  in the 
ventricular tissue of both humans and boxers with AC, suggesting that the loss of 
immunoreactive signal intensity is not due to loss of the total protein content in the myocyte, but 
likely results from failure of the altered proteins to appropriately incorporate in the desmosome 
preventing the formation of functional desmosomal units at the level of the intercalated disc 
(Kaplan, Gard et al. 2004; Oxford, Everitt et al. 2007; Asimaki, Tandri et al. 2009).    The 
decrease in the immunoreactive signal intensity for JUP serves as an additional indication that 
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alterations to the atrial intercalated disc are present in boxer AC.  However, a specific link 
between the alterations to the intercalated disc proteins such as JUP and the fatty or fibro-fatty 
myocardial replacement that characterizes AC has not been established. It has been suggested 
that the incorporation of abnormal desmosomal proteins into the intercalated disc leads to 
disruption of the mechanical coupling provided by the desmosome and that it facilitates myocyte 
detachment leading to cell injury, apoptosis, and the development of fatty or fibro-fatty 
myocardial replacement (Corrado, Basso et al. 2011; Asimaki and Saffitz 2012). This hypothesis 
appears to be a simplistic view of the disease process in AC, as it has been shown that 
desmosomal proteins also regulate changes in signaling pathways. Importantly, nuclear 
translocation of plakoglobin, in desmoplakin deficient mice, mediates changes in the Wnt 
pathway resulting in fibrosis, fatty replacement of the myocardium and ventricular arrhythmias 
(Garcia-Gras, Lombardi et al. 2006; Delmar and McKenna 2010).  It is likely that both the 
altered mechanical load and the interaction of the abnormal desmosomal proteins with signaling 
pathways contribute to the disease process in AC.    
Previous studies evaluating Cx43 in the ventricular tissue of  both humans and boxers 
affected with AC have shown decreased Cx43 immunoreactive signal intensity and altered 
localization, to the lateral aspect of the myocytes instead of forming part of the end to end 
connections (Kaplan, Gard et al. 2004; Oxford, Everitt et al. 2007).   In the present study, the 
“lateralization” of Cx43 could not be examined as the atrial myocardium normally expresses gap 
junctions at the site of end to end cell apposition and on the lateral aspect of the myocytes 
(Severs, Bruce et al. 2008). In the present study we did not see a decrease in the immunoreactive 
signal intensity for Cx43. However, a decrease in the number of Cx43 signals was noted via 
immunofluorescence in the AC boxers. The decrease in the amount of Cx43 was confirmed by 
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western blot analysis in the right atrium. Connexin 43 also appeared be decreased in the left 
atrium; however this did not reach statistical significance. We also failed to identify a difference 
between the control and AC boxers for Cx40 and Cx45. These proteins have been shown to be 
expressed in the atrial myocardium of dogs as part of the gap junction; however they have not 
been previously evaluated in AC affected animals (Davis, Kanter et al. 1994). No 
immunoreactive signal for Cx45 was noted in the samples collected, yet weak Cx45 bands were 
detected via western blot. It is possible that the anti-connexin 45 antibody did not yield an 
adequate signal with the immunofluorescence protocol used, or more likely there was minimal 
expression in the atrial samples collected, as Cx45 is primarily found in the sinus and 
atrioventricular node (Giovannone, Remo et al. 2012).  The amount of Cx45 present is these 
samples was likely below our level of detection via immunofluorescence but still identifiable 
with western blot (Oxford, Everitt et al. 2007).  Overall the changes seen via 
immunofluorescence and western blot suggest the presence of gap junction remodeling in the 
atria of AC affected boxers. Although gap junctions have not been shown to be directly affected 
by AC, their remodeling has been shown to occur in the ventricular tissue of both humans and 
boxers with AC (Kaplan, Gard et al. 2004; Kaplan, Gard et al. 2004; Oxford, Everitt et al. 2007).  
It is believed that normal gap junction function is dependent on the mechanical coupling 
provided by the desmosomes (Asimaki and Saffitz 2012). Therefore, once the mechanical 
connection provided by desmosomes has been disrupted, the gap junctions cannot sustain the 
remaining forces and remodeling occurs. This mechanism could explain why transmission 
electron microscopy of the atrial myocardium in the AC boxers showed internalized gap 
junctions near the widened altered structure sections of the intercalated disc. Signaling pathways 
triggered by the altered mechanical load, interaction with abnormal desmosomal proteins and 
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cytokine production are also suspected to play a role in gap junction remodeling (Asimaki and 
Saffitz 2012). For example, decreased expression of PKP-2 in cultured myocytes leads to 
decreased Cx43 expression, suggesting that increase mechanical load is not the only factor 
leading to gap junction remodeling in AC (Oxford, Musa et al. 2007).  Alterations to gap 
junction structure and function may lead to arrhythmogenesis (Severs, Bruce et al. 2008). For 
example, heterogeneous Cx43 expression in the myocardium of chimeric mice was linked to 
conduction abnormalities and occasional ventricular tachycardia (Gutstein, Morley et al. 2001).  
Our results are consistent with the notion that gap junction remodeling may contribute to the 
arrhythmogenic substrate created by the fatty or fibro-fatty myocardial replacement in AC.  
However, it should be noted that functional measurements evaluating this hypothesis have not 
been performed, as the majority of the studies evaluating gap junction remodeling in AC have 
been based on immunohistochemistry, which does not provide information about function or 
conduction changes (Asimaki and Saffitz 2012; Duffy 2012).  
Transmission electron microscopy showed adipocyte infiltration and areas of widened, 
altered structure of the intercalated disc in the AC boxers. Previous TEM studies in boxers and 
humans have shown adipocyte infiltration and a significantly lower number of desmosomes in 
the right ventricle of AC affected individuals compared to controls (Basso, Czarnowska et al. 
2006; Oxford, Danko et al. 2011). Quantification of the numbers of desmosomes was not 
possible in the present study due the small number of dogs evaluated with TEM. 
There are some limitations to in the interpretation of our results. Our results are based on 
a small number of boxers with AC and non-age matched healthy control. Ideally age matched 
boxers without AC would serve as controls. However, there is no test to ascertain that a healthy 
boxer is not an asymptomatic carrier of the disease. The TEM results are based on the 
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assessment of only 2 boxers, therefore additional samples are needed for evaluation and analysis 
of the ultrastructural changes in atrial myocytes of boxers with AC. Another limitation is that 
postmortem changes to the tissues that may alter our molecular results, as loss of intercalated 
disk integrity and gap junction remodeling, can occur soon after death.  To minimize this risk, 
cardiac tissues were collected no longer than 1 hour after euthanasia, and  Cx43 has been shown 
to be stable for 2 hours (Oxford, Everitt et al. 2007). We did not evaluate the location or 
expression of the striatin protein via immunofluorescence or western blot in these boxers. 
Genetic testing was performed in 5 out of the 13 boxers as part of their clinical evaluation; 
however, some of the boxer tissue was collected prior to the discovery of the striatin mutation 
and therefore DNA was not stored for genetic testing.  The majority of the boxers in the study 
were euthanized because of end stage AC. Therefore, it is possible that the molecular changes 
seen in this study are due to the end stage cardiac disease and heart failure rather than changes 
secondary to AC (Vatta, Marcus et al. 2007).  Lateralization and decreased Cx43 signal has been 
shown to occur secondary to myocardial infarction and congestive heart failure (Severs, Bruce et 
al. 2008; Kieken, Mutsaers et al. 2009). However, decreased expression of Cx43 and JUP has 
been shown to occur in a patient with Naxos disease, a recessive form of AC with cutaneous 
phenotype, before the presence of cardiac pathology (Kaplan, Gard et al. 2004). This suggests 
that the alterations in JUP and Cx43 do occur secondary to AC instead of being the result of 
congestive heart failure and end stage disease. Additional studies evaluating the expression of 
Cx43 and JUP in dogs with congestive heart failure due to diseases other than AC and in boxers 
with early AC would be needed for confirmation. 
The present study shows that the atrial myocardium of boxers with AC has histologic 
changes consistent with AC, decrease connexin 43 seen via immunofluorescence and western 
39 
 
blot, and weaker immunoreactive signal intensity for plakoglobin. Together, the results indicate 
that in addition to the ventricular myocardium, the atrial myocardium is affected in boxers with 
AC.  These findings support the use of the broader term of arrhythmogenic cardiomyopathy 
rather than arrhythmogenic right ventricular cardiomyopathy to describe this disease.  The 
decrease in the amount of Cx43 in conjunction with the histological changes could represent the 
substrate for the atrial arrhythmias associated with AC.   
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
 
References 
 
Asimaki, A. and J. E. Saffitz (2012). "Gap junctions and arrhythmogenic cardiomyopathy." 
Heart Rhythm 9(6): 992-995. 
Asimaki, A., H. Tandri, et al. (2009). "A new diagnostic test for arrhythmogenic right ventricular 
cardiomyopathy." N Engl J Med 360(11): 1075-1084. 
Azaouagh, A., S. Churzidse, et al. (2011). "Arrhythmogenic right ventricular 
cardiomyopathy/dysplasia: a review and update." Clin Res Cardiol 100(5): 383-394. 
Basso, C., D. Corrado, et al. (2009). "Arrhythmogenic right ventricular cardiomyopathy." The 
Lancet 373(9671): 1289-1300. 
Basso, C., E. Czarnowska, et al. (2006). "Ultrastructural evidence of intercalated disc 
remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy 
investigation on endomyocardial biopsies." Eur Heart J 27(15): 1847-1854. 
Basso, C., P. R. Fox, et al. (2004). "Arrhythmogenic right ventricular cardiomyopathy causing 
sudden cardiac death in boxer dogs: a new animal model of human disease." Circulation 
109(9): 1180-1185. 
Basso, C. and G. Thiene (2005). "Adipositas cordis, fatty infiltration of the right ventricle, and 
arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat?" Cardiovasc 
Pathol 14(1): 37-41. 
Basso, C., G. Thiene, et al. (1996). "Arrhythmogenic Right Ventricular Cardiomyopathy 
Dysplasia, Dystrophy, or Myocarditis? ." Circulation 94: 983-991. 
Baumwart, R. D., K. Meurs, et al. (2005). "Clinical, echocardiographic, and electrocardiographic 
abnormalities in Boxers with cardiomyopathy and left ventricular systolic dysfunction: 48 
cases (1985–2003)." Journal of the American Veterinary Medical Association 226(7): 
1102-1104. 
Baumwart, R. D., K. M. Meurs, et al. (2009). "Magnetic resonance imaging of right ventricular 
morphology and function in boxer dogs with arrhythmogenic right ventricular 
cardiomyopathy." Journal of Veterinary Internal Medicine 23: 271-274. 
41 
 
Beffagna, G., G. Occhi, et al. (2005). "Regulatory mutations in transforming growth factor-beta3 
gene cause arrhythmogenic right ventricular cardiomyopathy type 1." Cardiovasc Res 
65(2): 366-373. 
Burstein, B., P. Comtois, et al. (2009). "Changes in connexin expression and the atrial fibrillation 
substrate in congestive heart failure." Circ Res 105(12): 1213-1222. 
Chu, A. F., E. Zado, et al. (2010). "Atrial arrhythmias in patients with arrhythmogenic right 
ventricular cardiomyopathy/dysplasia and ventricular tachycardia." Am J Cardiol 106(5): 
720-722. 
Coonar, A. S., N. Protonotarios, et al. (1998). "Gene for arrhythmogenic right ventricular 
cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly 
hair (Naxos disease) maps to 17q21." Circulation 97(20): 2049-2058. 
Corrado, D., C. Basso, et al. (2011). "Molecular biology and clinical management of 
arrhythmogenic right ventricular cardiomyopathy/dysplasia." Heart 97(7): 530-539. 
Corrado, D., C. Basso, et al. (2000). "Arrhythmogenic right ventricular cardiomyopathy: 
diagnosis, prognosis, and treatment." Heart 83(5): 588-595. 
Corrado, D., C. Basso, et al. (1997). "Spectrum of clinicopathologic manifestations of 
arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study." J Am 
Coll Cardiol 30(6): 1512-1520. 
Cox, M. G., J. J. van der Smagt, et al. (2009). "New ECG criteria in arrhythmogenic right 
ventricular dysplasia/cardiomyopathy." Circ Arrhythm Electrophysiol 2(5): 524-530. 
Davis, L. M., H. L. Kanter, et al. (1994). "Distinct gap junction protein phenotypes in cardiac 
tissues with disparate conduction properties." J Am Coll Cardiol 24(4): 1124-1132. 
Delmar, M. (2012). "Connexin43 regulates sodium current; ankyrin-G modulates gap junctions: 
the intercalated disc exchanger." Cardiovasc Res 93(2): 220-222. 
Delmar, M. and W. J. McKenna (2010). "The Cardiac Desmosome and Arrhythmogenic 
Cardiomyopathies: From Gene to Disease." Circulation Research 107(6): 700-714. 
42 
 
Duffy, H. S. (2012). "The molecular mechanisms of gap junction remodeling." Heart Rhythm 
9(8): 1331-1334. 
Fontaine, G., F. Fontaliran, et al. (1998). "Arrhythmogenic Right Ventricular Cardiomyopathies : 
Clinical Forms and Main Differential Diagnose." Circulation 97: 1532-1535. 
Fox, P. R., B. J. Maron, et al. (2000). "Spontaneously occurring arrhythmogenic right ventricular 
cardiomyopathy in the domestic cat: A new animal model similar to the human disease." 
Circulation 102: 1863-1870. 
Garcia-Gras, E., R. Lombardi, et al. (2006). "Suppression of canonical Wnt/beta-catenin 
signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right 
ventricular cardiomyopathy." J Clin Invest 116(7): 2012-2021. 
Gavet, O. and J. Pines (2010). "Progressive activation of CyclinB1-Cdk1 coordinates entry to 
mitosis." Dev Cell 18(4): 533-543. 
Gerull, B., A. Heuser, et al. (2004). "Mutations in the desmosomal protein plakophilin-2 are 
common in arrhythmogenic right ventricular cardiomyopathy." Nat Genet 36(11): 1162-
1164. 
Giovannone, S., B. F. Remo, et al. (2012). "Channeling diversity: Gap junction expression in the 
heart." Heart Rhythm 9(7): 1159-1162. 
Gutstein, D. E., G. E. Morley, et al. (2001). "Heterogeneous expression of Gap junction channels 
in the heart leads to conduction defects and ventricular dysfunction." Circulation 104(10): 
1194-1199. 
Hariau, C. and D. J. Carpenter (2010). "Arrhythmogenic right ventricular cardiomyopathy in 
boxers." Compend Contin Educ Vet. 32(12): E1-E7. 
Harpster, N. K. (1983). Boxer cardiomyopathy. Current Veterinary Therapy VIII Small Animal 
Practice. Philadelphia, Pa, WB Saunders: 329-337. 
Harpster, N. K. (1991). "Boxer cardiomyopathy. A review of the long-term benefits of 
antiarrhythmic therapy." Vet Clin North Am Small Anim Pract 21(5): 989-1004. 
43 
 
Heuser, A., E. R. Plovie, et al. (2006). "Mutant desmocollin-2 causes arrhythmogenic right 
ventricular cardiomyopathy." Am J Hum Genet 79(6): 1081-1088. 
Kaplan, S., J. Gard, et al. (2004). "Remodeling of myocyte gap junctions in arrhythmogenic right 
ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease)." Heart 
Rhythm 1(1): 3-11. 
Kaplan, S. R., J. J. Gard, et al. (2004). "Structural and molecular pathology of the heart in 
Carvajal syndrome." Cardiovasc Pathol 13(1): 26-32. 
Kaplan, S. R., J. J. Gard, et al. (2004). "Remodeling of myocyte gap junctions in arrhythmogenic 
right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease)." Heart 
Rhythm 1(1): 3-11. 
Kieken, F., N. Mutsaers, et al. (2009). "Structural and molecular mechanisms of gap junction 
remodeling in epicardial border zone myocytes following myocardial infarction." Circ 
Res 104(9): 1103-1112. 
Kraus, M., N. S. Moïse, et al. (2002). "Morphology of Ventricular Arrhythmias in the Boxer as 
Measured by 12-Lead Electrocardiography with Pace-Mapping Comparison." Journal of 
Veterinary Internal Medicine 16: 153-158. 
Marcus, F. I., G. H. Fontaine, et al. (1982). "Right ventricular dysplasia: a report of 24 adult 
cases." Circulation 65(2): 384-398. 
Marcus, F. I., W. J. McKenna, et al. (2010). "Diagnosis of Arrhythmogenic Right Ventricular 
Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria." 
Circulation 121(13): 1533-1541. 
McKenna, W. J., G. Thiene, et al. (1994). "Diagnosis of arrhythmogenic right ventricular 
dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial 
Disease of the European Society of Cardiology and of the Scientific Council on 
Cardiomyopathies of the International Society and Federation of Cardiology." Heart 71: 
215-218. 
McKoy, G., N. Protonotarios, et al. (2000). "Identification of a deletion in plakoglobin in 
arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and 
woolly hair (Naxos disease)." Lancet 355(9221): 2119-2124. 
44 
 
Merner, N. D., K. A. Hodgkinson, et al. (2008). "Arrhythmogenic right ventricular 
cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a 
missense mutation in the TMEM43 gene." Am J Hum Genet 82(4): 809-821. 
Meurs, K. (2004). "Boxer dog cardiomyopathy: an update." Veterinary Clinics of North 
America: Small Animal Practice 34(5): 1235-1244. 
Meurs, K., A. W. Spier, et al. (1999). "Familial Ventricular Arrhythmias in Boxers." Journal of 
Veterinary Internal Medicine 13: 437-439. 
Meurs, K. M., V. A. Lacombe, et al. (2006). "Differential expression of the cardiac ryanodine 
receptor in normal and arrhythmogenic right ventricular cardiomyopathy canine hearts." 
Human Genetics 120(1): 111-118. 
Meurs, K. M., E. Mauceli, et al. (2010). "Genome-wide association identifies a deletion in the 3′ 
untranslated region of Striatin in a canine model of arrhythmogenic right ventricular 
cardiomyopathy." Human Genetics 128(3): 315-324. 
Meurs, K. M. and A. W. Spier (2009). Cardiomyopathy in Boxer Dogs. Kirk's Current 
Veterinary Therapy XIV. J. D. Bonagura. St. Louis, Missouri, Saunders Elsevier: 797-
799. 
Nelson, O. L., S. Lahmers, et al. (2006). "The use of an implantable cardioverter defibrillator in a 
Boxer Dog to control clinical signs of arrhythmogenic right ventricular cardiomyopathy." 
J Vet Intern Med 20(5): 1232-1237. 
Nogami, A., S. Adachi, et al. (1990). "Arrhythmogenic right ventricular dysplasia with sick sinus 
syndrome and atrioventricular conduction disturbance." Jpn Heart J 31(3): 417-423. 
Norgett, E. E., S. J. Hatsell, et al. (2000). "Recessive mutation in desmoplakin disrupts 
desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, 
woolly hair and keratoderma." Hum Mol Genet 9(18): 2761-2766. 
Norman, M., M. Simpson, et al. (2005). "Novel mutation in desmoplakin causes arrhythmogenic 
left ventricular cardiomyopathy." Circulation 112(5): 636-642. 
Oxford, E. M., C. G. Danko, et al. (2011). "Ultrastructural changes in cardiac myocytes from 
Boxer dogs with arrhythmogenic right ventricular cardiomyopathy." Journal of 
Veterinary Cardiology 13(2): 101-113. 
45 
 
Oxford, E. M., M. Everitt, et al. (2007). "Molecular composition of the intercalated disc in a 
spontaneous canine animal model of arrhythmogenic right ventricular 
dysplasia/cardiomyopathy." Heart Rhythm 4(9): 1196-1205. 
Oxford, E. M., H. Musa, et al. (2007). "Connexin43 Remodeling Caused by Inhibition of 
Plakophilin-2 Expression in Cardiac Cells." Circulation Research 101(7): 703-711. 
Oyama, M., S. Reiken, et al. (2008). "Arrhythmogenic right ventricular cardiomyopathy in Boxer 
dogs is associated with calstabin2 deficiency." Journal of Veterinary Cardiology 10(1): 1-
10. 
Pariaut, R., C. Saelinger, et al. (2011). "Implantable cardioverter-defibrillator in a German 
shepherd dog with ventricular arrhythmias." Journal of Veterinary Cardiology 13(3): 203-
210. 
Pariaut, R., C. Saelinger, et al. (2012). "Evaluation of shock waveform configuration on the 
defibrillation capacity of implantable cardioverter defibrillators in dogs." J Vet Cardiol. 
Pilichou, K., A. Nava, et al. (2006). "Mutations in desmoglein-2 gene are associated with 
arrhythmogenic right ventricular cardiomyopathy." Circulation 113(9): 1171-1179. 
Platonov, P. G., A. H. Christensen, et al. (2011). "Abnormal atrial activation is common in 
patients with arrhythmogenic right ventricular cardiomyopathy." J Electrocardiol 44(2): 
237-241. 
Rampazzo, A., A. Nava, et al. (2002). "Mutation in Human Desmoplakin Domain Binding to 
Plakoglobin Causes a Dominant Form of Arrhythmogenic Right Ventricular 
Cardiomyopathy." Am J Hum Genet 71: 1200-1206. 
Richardson, P., W. McKenna, et al. (1996). "Report of the 1995 World Health 
Organization/International Society and Federation of Cardiology Task Force on the 
Definition and Classification of cardiomyopathies." Circulation 93: 841-842. 
Saffitz, J. E. (2009). "Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell 
coupling." Heart Rhythm 6(8): S62-S65. 
Saffitz, J. E., K. Y. Hames, et al. (2007). "Remodeling of Gap Junctions in Ischemic and 
Nonischemic Forms of Heart Disease." Journal of Membrane Biology 218(1-3): 65-71. 
46 
 
Santilli, R. A., L. V. Bontempi, et al. (2011). "Ventricular tachycardia in English bulldogs with 
localised right ventricular outflow tract enlargement." J Small Anim Pract 52(11): 574-
580. 
Santilli, R. A., L. V. Bontempi, et al. (2009). "Outflow tract segmental arrhythmogenic right 
ventricular cardiomyopathy in an English Bulldog." J Vet Cardiol 11(1): 47-51. 
Sato, P. Y., W. Coombs, et al. (2011). "Interactions Between Ankyrin-G, Plakophilin-2, and 
Connexin43 at the Cardiac Intercalated Disc." Circulation Research 109(2): 193-201. 
Schneider, C. A., W. S. Rasband, et al. (2012). "NIH Image to ImageJ: 25 years of image 
analysis." Nat Methods 9(7): 671-675. 
Sen-Chowdhry, S., R. D. Morgan, et al. (2010). "Arrhythmogenic cardiomyopathy: etiology, 
diagnosis, and treatment." Annu Rev Med 61: 233-253. 
Severs, N. J., A. F. Bruce, et al. (2008). "Remodelling of gap junctions and connexin expression 
in diseased myocardium." Cardiovascular Research 80(1): 9-19. 
Shinbane, J. S., M. A. Wood, et al. (1997). "Tachycardia-induced cardiomyopathy: a review of 
animal models and clinical studies." J Am Coll Cardiol 29(4): 709-715. 
Spier, A. W. and K. Meurs (2004). "Evaluation of spontaneous variability in the frequency of 
ventricular arrhythmias in Boxers with arrhythmogenic right ventricular 
cardiomyopathy." Journal of the American Veterinary Medical Association 224(4): 538-
541. 
Spier, A. W. and K. Meurs (2004). "Use of signal-averaged electrocardiography in the evaluation 
of arrhythmogenic right ventricular cardiomyopathy in Boxers." Journal of the American 
Veterinary Medical Association 225: 1050-1055. 
Stern, J. A., K. M. Meurs, et al. (2010). "Ambulatory electrocardiographic evaluation of 
clinically normal adult Boxers." J Am Vet Med Assoc 236(4): 430-433. 
Takemura, N., K. Kono, et al. (2008). "Right atrial abnormalities in a patient with 
arrhythmogenic right ventricular cardiomyopathy without ventricular tachycardia." J 
Cardiol 51(3): 205-209. 
47 
 
Thiene, G., A. Nava, et al. (1988). "Right ventricular cardiomyopathy and sudden death in young 
people." N Engl J Med 318(3): 129-133. 
Thomason, J. D., M. S. Kraus, et al. (2008). "Bradycardia-associated syncope in 7 Boxers with 
ventricular tachycardia (2002-2005)." J Vet Intern Med 22(4): 931-936. 
Tiso, N., D. A. Stephan, et al. (2001). "Identification of mutations in the cardiac ryanodine 
receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy 
type 2 (ARVD2)." Hum Mol Genet 10(3): 189-194. 
Vatta, M., F. Marcus, et al. (2007). "Arrhythmogenic right ventricular cardiomyopathy: a ‘final 
common pathway’ that defines clinical phenotype." European Heart Journal 28: 529-530. 
Yoerger, D. M., F. Marcus, et al. (2005). "Echocardiographic findings in patients meeting task 
force criteria for arrhythmogenic right ventricular dysplasia: new insights from the 
multidisciplinary study of right ventricular dysplasia." J Am Coll Cardiol 45(6): 860-865. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
48 
 
Vita  
 
Jorge Luis Vila was born in 1982 in Mayaguez, Puerto Rico to Luis Vila and Wanda 
Colon.  He has two younger siblings, Lismary Vila and Joel Vila.  He attended Pomayuan 
Private School, graduating with high honors in May 2000.  After high school, he left Puerto Rico 
to attend Iowa State University to pursue a degree in Animal Science and pre-veterinary 
medicine.  In 2003, he was admitted into the Louisiana State University School of Veterinary 
Medicine.  During his time in veterinary school, he developed an interest in cardiology and 
decided to pursue specialization in this area.  After receiving the degree of Doctor of Veterinary 
Medicine in May, 2007, he went to Michigan State University to complete a small animal 
rotating internship.  Unfortunately, after completion of the internship he was not among the 
candidates selected to continue training in a cardiology residency.  He moved to Richmond, 
Virginia where he worked as an emergency veterinarian for a specialty and referral center.  
During this time he began to date Dr. Stephenie Abbott, a veterinary classmate who still lived in 
Louisiana.  After 2 years in Virginia, he decided to return to Louisiana to be closer to Stephenie 
and to pursue a Master degree, with the hope of becoming a more competitive candidate for a 
cardiology residency.  He enrolled in Louisiana State University in August 2010 and began work 
on his Master degree, originally in the cardiovascular pathophysiology lab under the guidance of 
Associate Professor Joseph Francis, B.V.Sc & A.H., M.V.Sc., Ph. D.  A year into the Master 
program, the opportunity to work with the Cardiology Service of Louisiana State University, in 
addition to the cardiovascular pathophysiology lab, presented itself.  At this time, he began to 
study under Assistant Professor of Veterinary Cardiology Romain Pariaut, D.V.M., Diplomate 
ACVIM-CA, as his major professor.  During this time, he married Dr. Stephenie Abbott in May 
2012.  In July 2012, he began a cardiology residency at Louisiana State University School of 
49 
 
Veterinary Medicine under the guidance of his major professor Dr. Pariaut and Assistant 
Professor of Veterinary Cardiology Caryn Reynolds, D.V.M., Diplomate ACVIM-CA. 
